Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 186,581 | 160,205 | 0 | 93,991 | 0 |
| Cost of Goods | 73,941 | 55,469 | N/A | 54,739 | N/A |
| Gross Profit | 112,640 | 104,736 | N/A | 39,252 | N/A |
| Operating Expenses | 81,551 | 237,217 | 0 | 108,174 | 0 |
| Operating Income | 32,030 | -132,012 | N/A | -68,183 | N/A |
| Other Income | 8,514 | 11,126 | 0 | 8,395 | 0 |
| Pre-tax Income | 40,544 | -120,886 | 0 | -59,788 | 0 |
| Income Tax | 14,234 | 4,435 | N/A | 5 | N/A |
| Net Income Continuous | 26,310 | -125,321 | N/A | -59,793 | N/A |
| Net Income | $26,310 | $-125,321 | $N/A | $-59,793 | $N/A |
| EPS Basic Total Ops | 0.14 | -0.68 | N/A | -0.32 | N/A |
| EPS Basic Continuous Ops | 0.14 | -0.68 | N/A | -0.33 | N/A |
| EPS Diluted Total Ops | 0.14 | -0.68 | N/A | -0.32 | N/A |
| EPS Diluted Continuous Ops | 0.14 | -0.68 | N/A | -0.33 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.34 | -0.05 | N/A | -0.40 |
| EBITDA(a) | $38,432 | $-128,105 | $N/A | $-62,461 | $N/A |